Lawyer profile
Greg Van Buiten
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- capital markets, Capital Markets, corporate
- Office
- Not stated
- Active in the record
- 2023 to 2026
Deal experience
Deals
4 announced deals in the record Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Latham & Watkins Advises on Allogene Therapeutics’ US$200.4 Million Public Offering of Common Stock 20 Apr 2026
Latham & Watkins Advises on BridgeBio’s US$500 Million Convertible Senior Notes Offering 27 Feb 2025
Latham & Watkins Advises Virgin Orbit in Voluntary Chapter 11 Proceedings 8 Apr 2023
Deal alerts PRO
Get an email when Greg Van Buiten is named on a newly announced deal.
Alerts come as one daily email at most.
Free account
Register free to unlock
- Every lawyer on every deal team, not just the first three
- The full recent-deal list on lawyer pages
- Claim and edit your own firm or lawyer profile
- Submit deals and corrections
- Request a Pro trial for your team
You have a free account. Everything in this column is open to you.
Pro
Get Pro for the full picture on Greg Van Buiten
- Complete deal history with keyword, type, sector and year filters
- Frequent co-counsel and the firms most often on the other side
- Repeat clients, as named in the announcements
- Market share and deals by year, sector and deal type
- Deal alerts by firm, lawyer, sector, deal type or jurisdiction
- CSV and Excel export, up to 1,000 rows a day, and custom reports
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile